TCT
GILD icon

TIAA CREF Trust’s Gilead Sciences GILD Stock Holding History

TIAA CREF Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$3.67M Sell
54,060
-56,926
-51% -$4M 0.03% 162
2016
Q4 		$7.95M Sell
110,986
-14,164
-11% -$1.05M 0.06% 110
2016
Q3 		$9.9M Sell
125,150
-21,541
-15% -$1.75M 0.08% 95
2016
Q2 		$12.2M Buy
146,691
+10,236
+8% +$908K 0.11% 80
2016
Q1 		$12.5M Buy
136,455
+26,203
+24% +$2.36M 0.12% 79
2015
Q4 		$11.2M Buy
110,252
+19,965
+22% +$2.08M 0.11% 90
2015
Q3 		$8.87M Buy
90,287
+11,640
+15% +$1.29M 0.1% 97
2015
Q2 		$9.21M Buy
78,647
+3,408
+5% +$372K 0.1% 94
2015
Q1 		$7.38M Buy
75,239
+6,039
+9% +$613K 0.09% 105
2014
Q4 		$6.52M Buy
69,200
+3,677
+6% +$380K 0.08% 113
2014
Q3 		$6.97M Buy
65,523
+7,148
+12% +$700K 0.1% 103
2014
Q2 		$4.84M Buy
58,375
+34,915
+149% +$2.72M 0.07% 120
2014
Q1 		$1.66M Buy
23,460
+2,862
+14% +$224K 0.03% 178
2013
Q4 		$1.55M Buy
20,598
+3,247
+19% +$226K 0.03% 179
2013
Q3 		$1.09M Sell
17,351
-247
-1% -$14.8K 0.02% 183
2013
Q2 		$902K Buy
+17,598
New +$917K 0.02% 193

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

TIAA CREF Trust's GILD Position: Q1 2017 in Review

TIAA CREF Trust reduced its Gilead Sciences (GILD) stake by 51% in Q1 2017, selling an estimated $4M and leaving 54,060 shares worth $3.67M. The position accounts for 0.03% of the portfolio, ranked #162.

TIAA CREF Trust first reported a position in GILD in Q2 2013 and has held it in 16 quarters since. The position peaked at $12.5M in Q1 2016. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • TIAA CREF Trust held 54,060 shares of Gilead Sciences worth $3.67M as of Q1 2017.
  • TIAA CREF Trust sold 56,926 Gilead Sciences shares in Q1 2017, an estimated $4M.
  • Gilead Sciences made up 0.03% of TIAA CREF Trust's portfolio in Q1 2017, its #162 holding.
  • TIAA CREF Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 16 quarters since.
  • TIAA CREF Trust's Gilead Sciences position peaked at $12.5M in Q1 2016.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.